Lijian Tao

机构：Central South University, Xiangya Hospital Central South University · ORCID：0000-0003-0816-7588

发表论文 200 篇 · 总被引 4308 次 · h-index 34

代表论文

• Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle/Syk/NF-κB signaling (2023 · Kidney International · 被引 79)
• Machine learning for the prediction of all-cause mortality in patients with sepsis-associated acute kidney injury during hospitalization (2023 · Frontiers in Immunology · 被引 50)
• Mefunidone alleviates silica-induced inflammation and fibrosis by inhibiting the TLR4-NF-κB/MAPK pathway and attenuating pyroptosis in murine macrophages (2024 · Biomedicine & Pharmacotherapy · 被引 29)
• Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway (2023 · Biomedicine & Pharmacotherapy · 被引 22)
• Succinate promotes pulmonary fibrosis through GPR91 and predicts death in idiopathic pulmonary fibrosis (2024 · Scientific Reports · 被引 19)
• Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease (2023 · Frontiers in Immunology · 被引 19)